First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
FBT Stock Price Chart Interactive Chart >
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $131.06 | 52-week high | $174.21 |
| Prev. close | $132.97 | 52-week low | $121.68 |
| Day low | $129.25 | Volume | 39,100 |
| Day high | $131.80 | Avg. volume | 48,826 |
| 50-day MA | $141.13 | Dividend yield | 1.67% |
| 200-day MA | $143.91 |
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.55% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 1.29B |
| Net Asset Value (NAV) | $132.97 |
| Options? | Yes |
| Total Holdings | 29 |
FBT Top Holdings
| Symbol | Company | % of Total |
| ALNY | Alnylam Pharmaceuticals | 4.89% |
| AGIO | Agios Pharmaceuticals | 4.66% |
| SRPT | Sarepta Therapeutics Inc | 4.65% |
| IONS | Ionis Pharmaceuticals | 4.01% |
| REGN | Regeneron Pharmaceuticals Inc | 3.97% |
| ACAD | ACADIA Pharmaceuticals Inc | 3.9% |
| NBIX | Neurocrine Biosciences Inc | 3.81% |
| ILMN | ILLUMINA INC | 3.59% |
| GILD | GILEAD SCI | 3.57% |
| FGEN | FibroGen Inc. | 3.53% |
FBT Price Returns
| 1-mo | -5.38% |
| 3-mo | -6.14% |
| 6-mo | -13.17% |
| 1-year | -23.16% |
| 3-year | 6.74% |
| 5-year | 8.81% |
| YTD | -19.08% |
| 2021 | -2.26% |
| 2020 | 12.96% |
| 2019 | 19.74% |
| 2018 | -0.30% |
| 2017 | 37.07% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||